Skip to main content

Cresco Labs Inc.

corporate_fare Company Profile

Cresco Labs Inc.

CRLBF·OTC·Life Sciences·CIK 0001832928

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. The company offers a diverse range of cannabis products, including flowers, vape pens, live resins, disposable pens, and extracts under its Cresco brand. Under the High Supply brand, it provides vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates. The Good News brand features vapes, gummies, and pre-rolls, while the Wonder Wellness Co. brand offers vapes and edibles. For tinctures, capsules, salves, and sublingual oils, the company uses the Remedi brand. Additionally, Cresco Labs Inc. sells cannabis flowers under the FloraCal brand and cannabis oils and various bites at multiple potency levels under the Mindy's brand, as well as the Loud*r brand. The company also provides cannabis-infused edibles under the Sunnyside brand. Cresco Labs Inc. is headquartered in Chicago, Illinois.

Cresco Labs Inc. (OTC:CRLBF) is a publicly traded company in the Life Sciences sector. Wiseek monitors CRLBF SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Cresco Labs Reports Q1 Loss Amid Revenue Decline; Highlights Transformative Cannabis Rescheduling & Strategic Expansion
  • Medical Cannabis Rescheduling to Schedule III Powers Cresco Labs' Q1 Growth
  • Cresco Labs Posts $162M Q4 Revenue, Boosts Margins Sequentially
  • Cresco Labs Establishes US$100M At-the-Market Offering for Capital Needs

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$655.85M
Net Income
-$135.41M
Diluted EPS
-$0.38
Op. Cash Flow
$72.89M
Free Cash Flow
$37.75M
Gross Profit
$324.57M
Operating Income
-$27.99M
Cash & Equivalents
$57.9M
Total Debt
$420.39M
Debt / Equity
1.23×
Net Margin
-20.6%
Shares Outstanding
355.01M sh
Source: 40-F · filed 2026-03-05 · accession 0001832928-26-000005

Insider Transactions

CRLBF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with C →
$0.82
52-week range · as of 2026-05-08 $0.4256 – $2.3
Market cap
$378.76M
Volume
712.2K (1.0× avg)
3-mo avg 711.6K
Live data · 2026-06-14 05:15 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CRLBF - Latest Insights

CRLBF
May 08, 2026, 7:51 AM EDT
Filing Type: 6-K
Importance Score:
8
Cresco Labs Reports Q1 Loss Amid Revenue Decline; Highlights Transformative Cannabis Rescheduling & Strategic Expansion
Price at Filing: $1.06
Real-time Price: $0.820 info
Change: -$0.240 (-23%) info
Market Cap: $378.76M info
Sentiment: Neutral
View Wiseek Article
CRLBF
May 08, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Medical Cannabis Rescheduling to Schedule III Powers Cresco Labs' Q1 Growth
Price at Filing: $1.06
Real-time Price: $0.820 info
Change: -$0.240 (-23%) info
Market Cap: $378.76M info
Sentiment: Positive
View Wiseek Article
CRLBF
Mar 05, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Cresco Labs Posts $162M Q4 Revenue, Boosts Margins Sequentially
Price at Filing: $0.975
Real-time Price: $0.820 info
Change: -$0.155 (-16%) info
Market Cap: $378.76M info
Sentiment: Positive
View Wiseek Article
CRLBF
Jan 30, 2026, 6:19 PM EST
Filing Type: 6-K
Importance Score:
8
Cresco Labs Establishes US$100M At-the-Market Offering for Capital Needs
Price at Filing: $1.04
Real-time Price: $0.820 info
Change: -$0.220 (-21%) info
Market Cap: $378.76M info
Sentiment: Negative
View Wiseek Article